Effects of elastic therapeutic taping on reducing drooling in children with neurological disorders: a systematic review of randomized controlled trials.

Krystal Tsz Ting Lam, Alex Tsz Wai Hung, Kendy Lau, Eric Kam Pui Lee
Author Information
  1. Krystal Tsz Ting Lam: Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
  2. Alex Tsz Wai Hung: Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
  3. Kendy Lau: Li Ping Medical Library, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
  4. Eric Kam Pui Lee: Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China. lkp032@cuhk.edu.hk. ORCID

Abstract

BACKGROUND & AIMS: Effective treatment for anterior drooling in children with neurological disorders can lead to improved social interactions, reduced physical complications such as perioral infections, and enhanced quality of life for both patients and their parents. Elastic therapeutic taping (ETT) has emerged a novel intervention for drooling, but its evidence was limited. This study systematically reviewed the effectiveness of ETT on reducing anterior drooling in children with neurological disorders.
METHODS: Multiple electronic databases, such as Ovid MEDLINE, Embase, and Cochrane Library were searched from inception till 30th October 2024. Randomized controlled trials (RCTs) were included if they: (a) used ETT as a treatment for drooling or swallowing difficulties; (b) included participants aged < 18 years old; (c) included participants with anterior drooling and neurological disorders; (d) compared effects of ETT alone or combined with other treatments (e.g. oral motor therapy (OMT)) with no taping, sham taping or other treatments, and (e) published in English. The Cochrane Risk-of-Bias tool was used to assess risk of bias for the included studies.
RESULTS: Seven parallel-arm RCTs, which were conducted in South/southwest Asia, Africa, South America and Middle East, were included. In total, 220 children aged 1 to 11 were included, of which 97 received solely ETT in 4 studies, while 24 received ETT plus OMT in 2 studies. ETT combined with OMT was more effective in reducing drooling in the included 2 RCTs, though the results of ETT alone were inconsistent, likely due to heterogeneity observed in control conditions, application methods, and outcome measures. No side effects were reported in all studies.
CONCLUSIONS: This review suggests that ETT combined with OMT is effective in reducing drooling in children with neurological disorders, with no evidence of side effects.
TRIAL REGISTRATION: (PROSPERO no.: CRD42023488664).

Keywords

References

  1. J Exerc Rehabil. 2016 Oct 31;12(5):456-462 [PMID: 27807525]
  2. Eur J Pediatr. 2024 Oct;183(10):4491-4498 [PMID: 39145887]
  3. Expert Rev Neurother. 2021 Feb;21(2):179-187 [PMID: 33222543]
  4. Int J Pediatr Otorhinolaryngol. 2022 Feb;153:111017 [PMID: 34974277]
  5. J Pediatr (Rio J). 2016 Nov - Dec;92(6):549-558 [PMID: 27281791]
  6. Int J Sports Phys Ther. 2017 Feb;12(1):85-93 [PMID: 28217419]
  7. Eur J Pediatr. 2022 Jul;181(7):2575-2592 [PMID: 35441248]
  8. Iran J Neurol. 2016 Oct 7;15(4):219-227 [PMID: 28435631]
  9. Cochrane Database Syst Rev. 2012 Feb 15;(2):CD008624 [PMID: 22336850]
  10. J Clin Med. 2024 Feb 09;13(4): [PMID: 38398310]
  11. Dev Neurorehabil. 2024 Jul-Aug;27(5-6):161-168 [PMID: 38967352]
  12. Trials. 2014 Jul 03;15:264 [PMID: 24993581]
  13. Cranio. 2024 Sep;42(5):499-506 [PMID: 34882511]
  14. Dev Med Child Neurol. 2019 Jan;61(1):39-48 [PMID: 30276810]
  15. J Phys Ther Sci. 2015 Nov;27(11):3355-7 [PMID: 26696697]
  16. Eur J Paediatr Dent. 2004 Sep;5(3):151-6 [PMID: 15471523]
  17. PLoS One. 2024 Apr 01;19(4):e0300881 [PMID: 38557691]
  18. BMJ. 2021 Mar 29;372:n71 [PMID: 33782057]
  19. Rev Neurol. 2019 Nov 1;69(9):353-362 [PMID: 31657447]
  20. Dev Neurorehabil. 2019 Jan;22(1):13-18 [PMID: 28933983]
  21. J Electromyogr Kinesiol. 2009 Dec;19(6):1092-9 [PMID: 19147374]
  22. Int J Pediatr Otorhinolaryngol. 2024 Sep;184:112057 [PMID: 39121685]
  23. Rev Assoc Med Bras (1992). 2024 Apr 22;70(3):e20230971 [PMID: 38655996]
  24. Dev Med Child Neurol. 2009 Jun;51(6):454-9 [PMID: 19207297]
  25. Ital J Pediatr. 2022 Jul 19;48(1):118 [PMID: 35854335]
  26. Health Technol Assess. 2003;7(1):1-76 [PMID: 12583822]
  27. Dev Med Child Neurol. 2012 Dec;54(12):1121-6 [PMID: 23094939]
  28. Turk J Phys Med Rehabil. 2023 Jun 07;69(4):434-443 [PMID: 38766591]
  29. Braz J Phys Ther. 2018 Jul - Aug;22(4):283-290 [PMID: 29728298]
  30. Dev Med Child Neurol. 2019 Nov;61(11):1249-1258 [PMID: 31328797]
  31. J Clin Epidemiol. 2021 Sep;137:209-217 [PMID: 33933579]
  32. BMJ. 2011 Oct 18;343:d5928 [PMID: 22008217]
  33. Dev Med Child Neurol. 2015 Jan;57(1):81-8 [PMID: 25213082]
  34. Int J Technol Assess Health Care. 2012 Apr;28(2):138-44 [PMID: 22559755]
  35. Neurosci Lett. 2017 Feb 15;640:1-5 [PMID: 28082150]
  36. Altern Ther Health Med. 2022 Mar;28(3):48-51 [PMID: 35180096]
  37. Arch Otolaryngol Head Neck Surg. 2009 Sep;135(9):924-31 [PMID: 19770427]

MeSH Term

Humans
Sialorrhea
Child
Randomized Controlled Trials as Topic
Nervous System Diseases
Child, Preschool
Adolescent

Word Cloud

Created with Highcharts 10.0.0ETTdroolingincludedchildrenneurologicaldisorderstapingreducingOMTstudiesanteriortherapeuticRCTseffectscombinedtreatmentElasticevidenceCochranecontrolledtrialsusedparticipantsalonetreatmentsereceived2effectivesidereviewBACKGROUND&AIMS:EffectivecanleadimprovedsocialinteractionsreducedphysicalcomplicationsperioralinfectionsenhancedqualitylifepatientsparentsemergednovelinterventionlimitedstudysystematicallyreviewedeffectivenessMETHODS:MultipleelectronicdatabasesOvidMEDLINEEmbaseLibrarysearchedinceptiontill30thOctober2024Randomizedthey:swallowingdifficultiesbaged < 18 yearsoldcdcomparedgoralmotortherapyshampublishedEnglishRisk-of-BiastoolassessriskbiasRESULTS:Sevenparallel-armconductedSouth/southwestAsiaAfricaSouthAmericaMiddleEasttotal220aged11197solely424plusthoughresultsinconsistentlikelydueheterogeneityobservedcontrolconditionsapplicationmethodsoutcomemeasuresreportedCONCLUSIONS:suggestsTRIALREGISTRATION:PROSPEROno:CRD42023488664Effectselasticdisorders:systematicrandomizedDroolingKinesio-tapingNeurological

Similar Articles

Cited By